Usage: hover your mouse-pointer anywhere on the image above to see an enlarged portion of the image. You can also just click the image to see the original-sized version.
|The VirusGEN® AAV Transfection Kit consists of two components: TransIT-VirusGEN® Transfection Reagent and VirusGEN® AAV Complex Formation Solution and Enhancer. All components of VirusGEN® AAV Transfection Kits (VirusGEN® AAV Transfection Kit, VirusGEN® SELECT AAV Transfection Kit and VirusGEN® GMP AAV Transfection Kit) are identical in formulation, which makes the transition from R&D to pre-clinical and commercial manufacturing seamless. However, additional quality release specifications are performed for VirusGEN® SELECT and GMP AAV Transfection Kits for improved compatibility with biopharmaceutical AAV manufacture. An even higher standard of quality is applied to VirusGEN® GMP AAV Transfection Kit, which is completely manufactured under cGMP (following U.S. 21 CFR 820 guidelines) in a dedicated production facility. For suspension 293 cells. → TransIT-VirusGEN® Transfection Reagent is designed to enhance delivery of packaging and transfer plasmids to adherent and suspension HEK 293 cell types to increase recombinant adeno-associated virus (AAV) and lentivirus production. Key benefits of TransIT-VirusGEN® Transfection Reagent include: • Performance - Efficient DNA delivery for production of high-titer viral vectors • Scalability - Efficient production from < 1 ml to large scale cultures • Flexibility - Compatible with different recombinant virus and cell culture systems • Animal Origin Free - Fully synthetic transfection reagent formulation
|1 Kit - for 1 L of cell culture
|Only available in Germany, Austria and Hungary
|Multiple storage conditions - see individual bottles for specific recommendations
|Go to webpage